Abstract Hypercholesterolemia

I selec this topic because in my opinion is very important determine if there are differences in the treatment for hypercholesterolemia to patients with and without psychiatric disease and if there are regarding the quality of cardiovascular risk reduction in primary care settings with a high prevalence of psychiatric disease.
For this study I take reference of Rebekah A. Kaplowitz and his paper of 2005

Method 

Surveyed and medical records were reviewed for demographic information, documented psychiatric disease, cardiovascular risk factors, prescription for cholesterol-lowering medication, and the level of the cholesterol in the blood 

Results: 

There are 76 subjects with psychiatric disease and 121 subjects without psychiatric disease

Subjects with and without psychiatric disease had similar clinical and demographic characteristics as well as rates of cholesterol testing.  Neither diagnosis of hypercholesterolemia nor prescription for cholesterol-lowering medication were associated with psychiatric disease. The mean serum total cholesterol was 15 mg/dL higher for patients with psychiatric disease than for those without.

Conclusion: 

The role of the physiotherapist is very important for research and education of societyabout the risks of this disease
Finally we can say that in this patient population, the presence of psychiatric disease was not associated with hypercholesterolemia testing, diagnosis, or treatment. We observed higher mean serum total cholesterol levels in subjects with psychiatric disease. But further study is needed to examine the implications of our findings.